Matthew Croughan

Company: PBS Biotech Inc.

Job title: Chief Technology Officer

Seminars:

mABs to Microcarriers: Applying Lessons Learned from Large-Scale Recombinant Protein Production to Advance Allogeneic Cell Therapy Manufacturing 12:30 pm

Allogeneic cell therapy manufacturing is currently where monoclonal antibody (mAB) manufacturing was 35 years ago: too expensive and unable to meet large market demands The breakthroughs that enabled commercial mAB manufacturing will be highlighted, including those that relied on extensive cell line adaptation. Similar breakthroughs are needed for allogeneic cell therapy manufacturing but will not rely on…Read more

day: Day One Track B AM